Page results
-
UCLH needs to reduce the amount we consume per patient, re-use and re-manufacture what we can and ensure that what we do use has minimal environmental impact. We also need to ensure our suppliers match our environmental ambitions. This page explores our progress so far.
-
Ensuring that UCLH staff understand the urgency of the climate crisis and support our net zero programme is crucial if we want to be successful in reaching our goal of net zero carbon emissions by 2031. Our patients must be kept informed of changes and we must work closely with other NHS organisations, including NHS England, if we are to deliver a successful programme. This page documents our progress to date.
-
A multi-disciplinary team involving UCLH and UCL has developed a way to monitor the progression of movement disorders using motion capture technology and AI.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
The UCLH trauma and orthopaedics team has reached a milestone of 1000 operations on hips and knees using the Mako robot.
-
3000 participants have been recruited to a clinical trial led by UCL and UCLH aimed at reducing the number of patients with breast cancer who are given chemotherapy unnecessarily.
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
-
Mark Emberton joined the board as a non-executive director on 1 September 2022. He is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London.
-
UCLH is committed to not only treat patients’ illnesses but to provide an environment and an experience which contributes to patients’ general wellbeing.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
File results
-
FOI/2023/0399 - Patient deaths while waiting to receive planned care/ patients waiting more than 18 weeks - 2022
-
FOI/2023/0415 - Contact details for senior staff at Estates and Facilities
-
FOI/2023/0425 - Trusts temp agency spend for doctors, nurses and allied health professionals (AHP) - 2022/23
-
FOI/2023/0430 - Number of operations performed to remove rectal foreign bodies
-
FOI/2023/0437 - Outsourced and insourced procedures for dermatology, endoscopy and gynaecology procedures from 2017/18-2022/23
-
FOI/2023/0438 - Outsourced and insourced procedures dermatology, endoscopy and gynaecological procedures
-
FOI/2023/0446 - Senior staff contact details
-
FOI/2023/0447 - Excessive exposure to Nitrous Oxide via Entonox from 2018-2023
-
FOI/2023/0450 - Pain relief options (remifentanil, entonox and sterile water injections) during labour
-
Neuroimmunology and CSF Laboratory User Handbook